Gene expression in tumors

by NanoVation | Mar 30, 2023 | Extrahepatic, Tissue, tumour

Adminstration route: i.v. Platform technology: lcLNP™ Modality: DNA Indication: not disclosed Strategy:...

Durable gene expression for treating genetic diseases

by NanoVation | Mar 30, 2023 | Liver, Tissue

Adminstration route: i.v. Platform technology: HepLNP Modality: DNA Indication: not disclosed Strategy:...

Gene expression for cancer immunotherapy

by NanoVation | Mar 30, 2023 | Blood/immune cells, bone marrow, Extrahepatic, spleen, Tissue

Adminstration route: i.v. Platform technology: lcLNP™ Modality: mRNA Indication: not disclosed Strategy:...

Gene editing in extrahepatic tissues for treating genetic diseases

by NanoVation | Mar 30, 2023 | Blood/immune cells, bone marrow, Extrahepatic, Tissue

Adminstration route: i.v. Platform technology: lcLNP™ Modality: mRNA/gRNA Indication: not disclosed Strategy:...

Gene expression for healthy aging

by NanoVation | Mar 30, 2023 | Tissue, Undisclosed

Adminstration route: i.v. Platform technology: combined Modality: mRNA Indication: not disclosed Strategy:...

mRNA vaccine for viral diseases

by NanoVation | Mar 30, 2023 | Blood/immune cells, Extrahepatic, Tissue, virus

Adminstration route: i.m. Platform technology: combined Modality: mRNA Indication: SARS & ASF Strategy:...